On the 2nd of March 2020, Kingdom of Saudi Arabia confirmed its first case of the coronavirus's newly emerging strain, causing coronavirus disease 2019 (COVID-19). Soon after, the number of confirmed cases started to increase nationally. In light of the emerging outbreak, all healthcare professionals, including pharmacists, began to function with maximum capacity and efforts. The Saudi Society of Clinical Pharmacy (SSCP) acknowledges the substantial impact pharmacists can play during outbreaks. Based on the existing scientific knowledge during this outbreak, the SSCP established an expert writing task force to conceptualize and draft the proposed recommendations that highlights the roles and responsibilities of pharmacists during epidemics and pandemics. The SSCP writing task force issued 28 recommendations. In addition to the national and institutional guidelines, these recommendations could serve as guidance for the impacted entities.

2020年3月2日，沙特阿拉伯王国确认了首例冠状病毒新出现株，导致2019年冠状病毒病（COVID-19）。此后不久，全国确诊病例数开始增​​加。鉴于即将爆发的疫情，包括药剂师在内的所有医疗保健专业人员都开始以最大的能力和最大的努力发挥作用。沙特临床药房学会（SSCP）承认，药剂师在疫情暴发期间可发挥巨大作用。基于此次爆发期间的现有科学知识，SSCP成立了一个专家撰写工作组，以概念化并起草建议的建议，以突出在流行病和大流行期间药剂师的作用和职责。SSCP撰写工作队发布了28条建议。